Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 384741 - 384760 out of 498428 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Saudi Arabia | (L04AC10) secukinumab (adm: P) | COSENTYX 75 mg/0.5 ml Solution for injection in pre-filled syringe | 1 Pre-filled syringe, 75 mg, Subcutaneous use, Solution for injection, 75mg , Pre-filled syringe, Solution for injection | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Psoriatic; Psoriasis; Spondylitis, Ankylosing | NOVARTISPHARMAAG / NOVARTISPharmaSteinAG |
| Saudi Arabia | (L04AC14) sarilumab (adm: P) | KEVZARA 150MG SOL. FOR INJ. IN PRE - FILLED PEN | 2 Pre-filled pen, 150 mg, Subcutaneous use, Solution for injection, 150mg , Pre-filled pen, Solution for injection | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | SANOFIWINTHROPINDUSTRIE / SANOFIWINTHROPINDUSTRIE |
| Saudi Arabia | (L04AC14) sarilumab (adm: P) | KEVZARA 150MG SOL. FOR INJ. IN PRE-FILLED SYRINGE | 2 Pre-filled syringe, 150 mg, Subcutaneous use, Solution for injection, 150mg , Pre-filled syringe, Solution for injection | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | SANOFIWINTHROPINDUSTRIE / SANOFIWINTHROPINDUSTRIE |
| Saudi Arabia | (L04AC14) sarilumab (adm: P) | KEVZARA 200MG SOL. FOR INJ. IN PRE - FILLED PEN | 2 Pre-filled pen, 200 mg, Subcutaneous use, Solution for injection, 200mg , Pre-filled pen, Solution for injection | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | SANOFIWINTHROPINDUSTRIE / SANOFIWINTHROPINDUSTRIE |
| Saudi Arabia | (L04AC14) sarilumab (adm: P) | KEVZARA 200MG SOL. FOR INJ. IN PRE-FILLED SYRINGE | 2 Pre-filled syringe, 200 mg, Subcutaneous use, Solution for injection, 200mg , Pre-filled syringe, Solution for injection | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | SANOFIWINTHROPINDUSTRIE / SANOFIWINTHROPINDUSTRIE |
| Saudi Arabia | (L04AC16) guselkumab (adm: P) | TREMFYA 100 MG/ML | 1 Pre-filled syringe, 1ml, 100 mg/ml, Subcutaneous use, Solution for injection, 100mg/ml , Pre-filled syringe, Solution for injection | Retail price without vat |
$0-0 |
$0-0 |
Psoriasis | JANSSEN-CILAG / CilagAG,Schaffhausen,Switzerland |
| Saudi Arabia | (L04AC18) risankizumab (adm: P) | Skyrizi 600 mg per 10 ml | 1 Vial, 10ml, 60 mg/ml, Intravenous use, Solution for infusion, 60mg/ml , Vial, Solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Psoriasis; Arthritis, Psoriatic | AbbVieInc / AbbVieLimited |
| Saudi Arabia | (L04AC21) bimekizumab (adm: P) | BIMZELX | 2 Pre-filled pen, 1ml, 160 mg/ml, Subcutaneous use, Solution for injection in pre-filled pen, 160mg/ml , Pre-filled pen, Solution for injection in pre-filled pen | Retail price without vat |
$0-0 |
$0-0 |
Psoriasis | UCBPharmaS.A. / VETTERPHARMA-FERTIGUNG,GMBH&CO.KG |
| Saudi Arabia | (L04AC22) spesolimab (adm: P, course dose) | Spevigo 450 mg per 7.5 ml | 2 Vial, 7,5ml, 60 g/l, Intravenous use, Solution for infusion, 60g/l , Vial, Solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Psoriasis | BoehringerIngelheimPharmaGmbHandCoKG / BoehringerIngelheimPharmaGmbH&Co.KG |
| Saudi Arabia | (L04AD01) ciclosporin | Effyren | 30 Blister, 25 mg, Oral use, Capsule, hard, 25mg , Blister, Capsule, hard | Retail price without vat |
$0-0 |
$0-0 |
n/a | PanaceaBiotecPharmaLtd / PanaceaBiotecPharmaLtd |
| Saudi Arabia | (L04AD01) ciclosporin | SANDIMMUN NEORAL 100MG CAPS | 50 Blister, 100 mg, Oral use, Capsule, 100mg , Blister, Capsule | Retail price without vat |
$0-0 |
$0-0 |
n/a | NOVARTISPHARMAAG / CATALENT |
| Saudi Arabia | (L04AD01) ciclosporin | SANDIMMUN NEORAL 25MG CAPS | 50 Blister, 25 mg, Oral use, Capsule, 25mg , Blister, Capsule | Retail price without vat |
$0-0 |
$0-0 |
n/a | NOVARTISPHARMAAG / CATALENT |
| Saudi Arabia | (L04AD01) ciclosporin | SANDIMMUN NEORAL 50MG CAP | 50 Blister, 50 mg, Oral use, Capsule, 50mg , Blister, Capsule | Retail price without vat |
$0-0 |
$0-0 |
n/a | NOVARTISPHARMAAG / CATALENT |
| Saudi Arabia | (L04AD02) tacrolimus | TACROZ 0.03% OINTMENT | 1 Tube, 10g, 0.03 %, Topical, Ointment, 0.03% , Tube, Ointment | Retail price without vat |
$0-0 |
$0-0 |
n/a | GlenmarkPharmaceuticalsLimited / GlenmarkPharmaceuticalsLimited-Baddi |
| Saudi Arabia | (L04AD02) tacrolimus | TACROZ FORTE OINTMENT | 1 Tube, 10g, 0.1 %, Topical, Ointment, 0.1% , Tube, Ointment | Retail price without vat |
$0-0 |
$0-0 |
n/a | GlenmarkPharmaceuticalsLimited / GlenmarkPharmaceuticalsLimited-Baddi |
| Saudi Arabia | (L04AD02) tacrolimus | VIOTOPIC 0.03% ointment | 1 Tube, 30g, 0.03 %, Topical, Ointment, 0.03% , Tube, Ointment | Retail price without vat |
$0-0 |
$0-0 |
n/a | JazeeraPharmaceuticalIndustries(JPI) / JazeeraPharmaceuticalIndustries(JPI) |
| Saudi Arabia | (L04AD02) tacrolimus | VIOTOPIC 0.1% ointment | 1 Tube, 30g, 0.1 %, Topical, Ointment, 0.1% , Tube, Ointment | Retail price without vat |
$0-0 |
$0-0 |
n/a | JazeeraPharmaceuticalIndustries(JPI) / JazeeraPharmaceuticalIndustries(JPI) |
| Saudi Arabia | (L04AD02) tacrolimus | ADVAGRAF 0.5MG PROLONGED RELEASE CAPSULE | 100 Blister, 0.5 mg, Oral use, Prolonged-release capsule, hard, 0.5mg , Blister, Prolonged-release capsule, hard | Retail price without vat |
$0-0 |
$0-0 |
Graft Rejection | JazeeraPharmaceuticalIndustries(JPI) / AstellasPharma |
| Saudi Arabia | (L04AD02) tacrolimus | ADVAGRAF 1MG PROLONGED RELEASE CAPSULE | 100 Blister, 1 mg, Oral use, Prolonged-release capsule, hard, 1mg , Blister, Prolonged-release capsule, hard | Retail price without vat |
$0-0 |
$0-0 |
Graft Rejection | JazeeraPharmaceuticalIndustries(JPI) / AstellasPharma |
| Saudi Arabia | (L04AD02) tacrolimus | ADVAGRAF 3MG PROLONGED RELEASE CAPSULE | 100 Blister, 3 mg, Oral use, Prolonged-release capsule, hard, 3mg , Blister, Prolonged-release capsule, hard | Retail price without vat |
$0-0 |
$0-0 |
Graft Rejection | JazeeraPharmaceuticalIndustries(JPI) / AstellasPharma |
Pages
